I agree, their planning and follow through has been very good. The Sept 12 NR announced the beginning of a 3 - 4 month field test; which would mean it's coming to an end in the next 2 to 6 wks. I don't think BTV exposure was happenstance. Very early on in 2013 is, imo, no later than April... anything after that takes us into mid year and totally loses the impact of "very early". My thoughts are that news will push our stock up before the end of February. And that's not to say that it can't or won't show some inrease before then. I've been waiting a long time on this one. A couple of concerns: European economy and time frame remaining for FDA approval. Obviously the powers that be haven't expedited the process or it would have been announced. Regular processing could be due to melafind already being expedited through the FDA process (because they were the first to apply for this type of device and there was more urgency to get it to market). Still, It's looking good and I'm starting to get excited about some very nice profit taking.
gaser, you mentioned leasing program... I haven't talked with the company in several months and don't recall anything being said about a leasing program. I was under the impression that we were going for a one time sale price as opposed to Mela's leasing strategy... did I miss something?